ArmaVir Partners makes direct equity investments in operating companies and unique assets.
ArmaVir Partners, formerly the Ramius Private Investments Group makes direct equity investments in operating companies and unique assets. It takes an active approach and makes control or significant minority investments in small-to-mid-sized operating companies. It also looks to make minority investments in select high growth private companies. In 2018, Armavir Partners spun out of its former parent, Cowen Inc. ArmaVir Partners has over $300 million in assets under management. ArmaVir Partners is actively seeking new investment opportunities in North America and Western Europe. Typically it looks to invest $10-100+ million. The firm is generalists, with significant experience in telecommunications, consumer products, industrials, financial services, and renewable energy.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 25, 2012
Bluebird Bio
|
Series D | $60M | Biotechnology | — |